Complement and demyelinating disease: No MAC needed?
- 1 August 2006
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 52 (1) , 58-68
- https://doi.org/10.1016/j.brainresrev.2005.12.002
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway responseJournal of Clinical Investigation, 2005
- Identification of complement 5a‐like receptor (C5L2) from astrocytes: characterization of anti‐inflammatory propertiesJournal of Neurochemistry, 2005
- Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammationThe FASEB Journal, 2003
- Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritisImmunology, 2001
- Expression of a Functional Anaphylatoxin C3a Receptor by AstrocytesJournal of Neurochemistry, 1998
- Novel complement inhibitorsExpert Opinion on Investigational Drugs, 1998
- Production of complement component C3 in vivo following 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin exposureJournal of Toxicology and Environmental Health, 1993
- Binding specificity and presynaptic action of anaphylatoxin C5a in rat brainBrain, Behavior, and Immunity, 1989
- Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamusJournal of Neuroimmunology, 1983
- EXPERIMENTAL AUTOIMMUNE ENCEPHALO‐MYELITIS IN MICE: GENETIC CONTROL OF SUSCEPTIBILITY*International Journal of Immunogenetics, 1976